Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...
This article and associated images are based on a poster originally authored by T Duboys, K Bergerhoff, E Coquerel, P Ananthanarayanan, J Wenda, A Dechelette, G Mary, MN Bellazrak, A Kumar, RFX Tomasi ...
Issued patent and new reagent launch position MICRO-TAG® as a real-time cellular platform for unlocking challenging drug targets. MICRO-TAG enables discovery teams to unlock challenging drug targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results